Order results by:
| Issue | Title | |
| Vol 20, No 2 (2024) | Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina | ||
| "... (Omega-3 PUFAs) on the parameters of ambulatory blood pressure monitoring (ABPM), 24-hour ..." | ||
| Vol 2, No 3 (2006) | NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION | Abstract similar documents |
| A. I. Martinov, V. L. Chomenko | ||
| "... and normalization of plasma lipid profile. Omega-3 PUFAs in large dozes show antiatherosclerotic effect. Clinical ..." | ||
| Vol 16, No 3 (2020) | The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... One of the trends in modern cardiology is the use of omega-3 polyunsaturated fatty acids (ω-3 PUFA ..." | ||
| Vol 9, No 1 (2013) | THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS | Abstract similar documents |
| A. O. Malygin, V. L. Doshchitsin | ||
| "... Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic ..." | ||
| Vol 8, No 1 (2012) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... (PUFA) - eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids – in a number of cardiovascular diseases ..." | ||
| Vol 18, No 2 (2022) | Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova | ||
| "... and clinical studies indicating the use of ω-3 PUFA (polyunsaturated fatty acids) contributes to reduce ..." | ||
| Vol 4, No 3 (2008) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION | Abstract similar documents |
| A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk | ||
| "... Aim. To estimate an efficacy of therapy with ω-3 polyunsaturated fatty acids (PUFA) in patients ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... Aim. To estimate the role of omega-3 polyunsaturated fatty acids (PUFAs) administration in atrial ..." | ||
| Vol 19, No 3 (2023) | Nutraceutical support in the prevention and treatment of cardiovascular diseases | Abstract similar documents |
| E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka | ||
| "... the short-term effects of taking omega-3 polyunsaturated fatty acids (effect on the blood lipid spectrum ..." | ||
| Vol 11, No 3 (2015) | OMEGA-3 FATTY ACIDS AND AGE-RELATED DISEASES: REALITIES AND PROSPECTS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... Efficacy of omega-3 fatty acids in cardiology is so high that in many countries omega-3 fatty ..." | ||
| Vol 8, No 2 (2012) | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya | ||
| "... A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally ..." | ||
| Vol 15, No 2 (2019) | Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics | Abstract similar documents |
| G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov | ||
| "... of its intolerance or if the triglyceride target level is not reached, ethyl esters of omega-3 ..." | ||
| Vol 3, No 1 (2007) | EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| R. M. Zaslavskaya, G. V. Lilitsa, Ye. V. Kalinina, I. A. Komissarova, L. N. Maximova | ||
| "... of lipids (POL) and cell anti-oxidant protection were implemented. Results. Eltacine increased in tolerance ..." | ||
| Vol 8, No 1 (2012) | URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL | similar documents |
| S. von Haehling, J. C. Schefold, E. A. Jankowska, J. Springer, A. Vazir, P. R. Kalra, A. Sandek, G. Fauler, T. Stojakovic, M. Trauner, P. Ponikowski, H-D. Volk, W. Doehner, A. J. S. Coats, P. A. Poole-Wilson, S. D. Anker | ||
| "... одноцентровое двойное слепое рандомизированное плацебо-контролируемое перекрестное исследование УДХК у 17 ..." | ||
| Vol 9, No 5 (2013) | LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY | Abstract similar documents |
| O. I. Afanasieva, S. N. Pokrovsky | ||
| "... Antisense oligonucleotides (ASO) technology in elaboration of drugs for lipid metabolism ..." | ||
| Vol 12, No 3 (2016) | EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
| "... cover issues of efficacy and safety of lipid-lowering therapy in primary and secondary prevention ..." | ||
| Vol 5, No 6 (2009) | INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS | Abstract similar documents |
| A. A. Usanova, A. A. Aleksandrovsky, A. V. Zorkina, O. M. Kiselеv | ||
| "... Aim. To study influence of enalapril, digoxin, atenolol and diltiazem on lipid peroxidation ..." | ||
| Vol 7, No 3 (2011) | EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY | similar documents |
| M. A. Ninci, R. Magliocca, A. Malliani | ||
| "... двойное слепое плацебо-контролируемое исследование включены 144 больных в возрасте 60-85 лет, разделенных ..." | ||
| Vol 8, No 5 (2012) | LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS | Abstract similar documents |
| A. N. Meshkov | ||
| "... Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results ..." | ||
| Vol 17, No 1 (2021) | Lipid Clinic is an Efficacious Model of Preventive Medicine | Abstract PDF (Eng) similar documents |
| A. V. Blokhina, A. I. Ershova, A. N. Meshkov, A. S. Limonova, V. I. Mikhailina, O. M. Drapkina | ||
| "... Aim. To characterize patients accessing lipid clinic and assess the efficiency of treatment ..." | ||
| Vol 8, No 2 (2012) | CLINICAL IMPLICATION OF FATTY ACID CHANGES IN PATIENTS WITH PRIMARY GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| N. N. Kushnarenko, A. V. Govorin | ||
| "... acids levels in lipids of erythrocyte membranes in patients with primary gout associated with arterial ..." | ||
| Vol 13, No 5 (2017) | AGE AND GENDER PECULIARITIES OF BLOOD LIPIDS IN URBAN RESIDENTS (CROSS-SECTIONAL STUDY RESULTS) | Abstract similar documents |
| S. A. Urazgildeeva, M. Yu. Nizhegorodcev, P. S. Sadovnikov, A. Yu. Olkhovik, D. Yu. Nokhrin, M. V. Muzalevskaya, I. V. Shugurova, D. G. Malenkovskaya, A. V. Tregubov, V. S. Gurevich | ||
| "... Aim. To analyze the results of measurements of the blood lipid spectrum of urban residents ..." | ||
| Vol 9, No 2 (2013) | MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina | ||
| "... Aim. To assess the quality of lipid-lowering therapy in high risk patients with cardiovascular ..." | ||
| Vol 11, No 5 (2015) | Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis | Abstract similar documents |
| N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov | ||
| "... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..." | ||
| Vol 11, No 5 (2015) | Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation | Abstract similar documents |
| E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov | ||
| "... arthritis (RA) is accompanied by deterioration of blood lipid profile. Aim. To study changes in serum lipid ..." | ||
| Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
| V. A. Sergeeva | ||
| "... Aim. To study the lipid-lowering therapy, the adequacy of its control, as well as the awareness ..." | ||
| Vol 14, No 5 (2018) | Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov | ||
| "... Aim. To assess the economic burden associated with the absence of lipid-lowering therapy (LLT ..." | ||
| Vol 17, No 6 (2021) | Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident | Abstract similar documents |
| S. A. Boytsov, M. A. Piradov, M. M. Tanashyan, I. A. Voznjouk, M. V. Ezhov, E. V. Oschepkova, I. V. Sergienko, N. A. Shamalov, S. N. Yanishevskiy | ||
| "... of atherothrombotic genesis, namely lipid metabolism disorders, the modern evidence base for lipid-lowering therapy ..." | ||
| Vol 20, No 4 (2024) | Increased lipoprotein (a) as an additional factor in the failure to achieve target blood pressure levels and lipid spectrum optimal parameters in patients with arterial hypertension and multifocal atherosclerosis | Abstract similar documents |
| S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... Aim. To establish the frequency of achieving target of blood pressure (BP) levels and lipid ..." | ||
| Vol 19, No 2 (2023) | Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) | Abstract similar documents |
| M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov | ||
| "... Aim. To study the frequency of prescriptions of various types of lipid-lowering therapy ..." | ||
| Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
| "... Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high ..." | ||
| Vol 6, No 1 (2010) | PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| E. V. Horolets, L. A. Haisheva, S. V. Shlyk, L. I. Katelnitskaya | ||
| "... Aim. To study purine metabolism and lipid peroxidation in patients with acute myocardial ..." | ||
| Vol 17, No 6 (2021) | PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center | Abstract similar documents |
| A. V. Blokhina, A. I. Ershova, A. S. Limonova, O. V. Kopylova, A. N. Meshkov, O. M. Drapkina | ||
| "... of their treatment in a specialized lipid center. Material and methods. A retrospective analysis of the medical ..." | ||
| Vol 6, No 2 (2010) | CHANGE IN BALANCE BETWEEN ACTIVITY OF LIPID PEROXIDATION, ANTIOXIDANT SYSTEM AND FERRUM CONTENT IN RATS WITH EXPERIMENTAL MYOCARDIAL INFARCTION | Abstract similar documents |
| L. D. Hidirova | ||
| "... Aim. To study the balance between activity of lipid peroxidation, antioxidant system and ferrum ..." | ||
| Vol 6, No 4 (2010) | EFFECTS OF ACUTE PHYSICAL EXERCISE OF VARYING INTENSITY ON LIPID METABOLISM IN MIDDLE AGED MEN | Abstract similar documents |
| G. E. Roytberg, I. D. Slastnikova, O. Ju. Dmitrieva, T. I. Ushakova | ||
| "... Aim. To investigate effects of acute physical exercise of varying intensity on lipid metabolism ..." | ||
| Vol 10, No 5 (2014) | EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova | ||
| "... into the study after 10-14 days of the acute Q-MI onset. Determination of blood lipids profile, alanine ..." | ||
| Vol 1, No 2 (2005) | ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov | ||
| "... , microalbuminuria and β2-microglobulinuria levels were defined, figures of lipid and glucose metabolism were studied ..." | ||
| Vol 3, No 3 (2007) | THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova | ||
| "... Aim. To study the effect of treatment with metabolic corrector mildronate on lipid profile ..." | ||
| Vol 14, No 3 (2018) | HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE | Abstract similar documents |
| O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta | ||
| "... . The issues of lipid-lowering therapy with statins in the aspect of stroke prevention are discussed ..." | ||
| Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... and rosuvastatin is an effective drug that allows achieving not only adequate hypotensive and lipid-lowering ..." | ||
| Vol 2, No 3 (2006) | EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. V. Shabalin, Yu. I. Ragino, S. A. Lyubimtseva, Ya. V. Polonskaya, M. V. Ivanova | ||
| "... in LDL), initial level of lipid peroxidation (LPO) products in LDL, LDL resistance to oxidation and blood ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| Vol 18, No 4 (2022) | Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina | ||
| "... in ESSE RF (1) and 3.8 years in ESSE RF(2). Analysis was performed for three lipid variables: total ..." | ||
| Vol 18, No 3 (2022) | Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER | Abstract similar documents |
| I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk | ||
| "... Aim. To study the dynamics of the lipid profile of hypertensive patients with dyslipidemia who ..." | ||
| Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
| S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
| "... Aim. To estimate the effectiveness of lipid-lowering therapy (LLT) at outpatient and hospital ..." | ||
| Vol 6, No 1 (2010) | EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS | Abstract PDF (Eng) similar documents |
| D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova | ||
| "... Aim. To study efficacy of moderate-intensity physical training (PT) and evaluate lipid-lowering ..." | ||
| Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
| M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
| "... Aim. To study the anti-inflammatory effects of intensive lipid-lowering therapy and genetic ..." | ||
| Vol 14, No 1 (2018) | THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina | ||
| "... Aim. To conduct a comparative study of the changes in blood lipids profiles in populations ..." | ||
| Vol 11, No 1 (2015) | ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE | Abstract similar documents |
| M. V. Solodun, S. S. Yakushin | ||
| "... . All patients were prescribed atorvastatin. A group of 65 people in whom lipid levels were studied ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| Vol 15, No 4 (2019) | The Association of Smoking Status and Intensity of Smoking with Blood Lipid Spectrum in a Sample of Middle-Aged Men | Abstract similar documents |
| A. A. Alexandrov, V. B. Rozanov, M. B. Kotova, V. A. Dadaeva, E. I. Ivanova | ||
| Vol 17, No 6 (2021) | Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia | Abstract similar documents |
| D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash | ||
| "... , hypertension, smoking, alcohol consumption and an increase in the number of respondents taking lipid-lowering ..." | ||
| Vol 19, No 6 (2023) | New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist | Abstract similar documents |
| A. B. Skiba, M. V. Menzorov, V. D. Puchek, I. M. Buchin, I. I. Polyakov, E. N. Menzorova | ||
| "... in the modern paradigm for dyslipidemia treatment from high-intensity statin therapy to high-intensity lipid ..." | ||
| Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
| I. V. Sergienko, A. A. Ansheles | ||
| "... and Moscow region patients with hypercholesterolemia (HCh) based on lipid spectrum and instrumental methods ..." | ||
| Vol 6, No 3 (2010) | EFFECT OF COMPLEX HOMEOPATHIC DRUG CONTAINING COENZYME Q ON PARAMETERS OF OXIDATIVE STRESS AND HEMODYNAMICS IN EXPERIMANTAL DIABETES MELLITUS | Abstract similar documents |
| S. G. Dzugkoev, V. A. Metelskaya, I. V. Mozhaeva, F. S. Dzugkoeva | ||
| "... control group. The parameters of macro- and microhemodynamic, lipid peroxidation, Na,K-ATPase activity ..." | ||
| Vol 14, No 6 (2018) | The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial | Abstract PDF (Eng) similar documents |
| Yu. A. Karpov | ||
| Vol 2, No 2 (2006) | THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL | Abstract similar documents |
| Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto | ||
| "... Aim. To evaluate effects of long-term treatment with rilmenidine compared with atenolol on lipid ..." | ||
| Vol 20, No 5 (2024) | Russian extreme hypertriglyceridemia registy (REGGI): a call to action | Abstract similar documents |
| U. V. Chubykina, M. V. Ezhov, A. A. Sokolov, P. A. Vasiluev, O. N. Ivanova, E. Y. Zakharova | ||
| Vol 21, No 1 (2025) | Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment | Abstract similar documents |
| A. M. Namitokov, U. V. Chubykina, V. K. Zafiraki, M. V. Ezhov | ||
| "... ≥180 mg/dL. The diagnosis of heterozygous FH was confirmed using the Dutch Lipid Clinic Network (DLCN ..." | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... ; p<0.001) after 6 months was found in patients treated with lipid-lowering therapy in combination ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... Aim. To study the effectiveness of achievement of lipid profile target levels and safety ..." | ||
| Vol 14, No 5 (2018) | Basic Anthropometric Indices and Diabetes Mellitus Type 2 in Russian Population | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel, S. A. Shalnova, A. D. Deev, Yu. A. Balanova, S. E. Evstifeeva, Yu. V. Zhernakova, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, O. P. Rotar, E. V. Shlyakhto, S. A. Boytsov | ||
| "... circumference (WC), waist-to-height ratio (WHR), lipid accumulation product index (LAPI), visceral obesity index ..." | ||
| Vol 1, No 2 (2005) | STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY | Abstract similar documents |
| Y. A. Karpov | ||
| "... , LIPID, WOSCOPS, AFCAPS/TexCAPS, HPS, ASCOT-LLA, CARDS) is demonstrated. Recommendations for statines ..." | ||
| Vol 21, No 2 (2025) | Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case) | Abstract similar documents |
| A. V. Melekhov, S. V. Borisovskaya, N. S. Gavrilina, I. I. Gaponova, I. G. Nikitin, O. A. Ettinger | ||
| Vol 13, No 4 (2017) | PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW | Abstract similar documents |
| I. S. Yavelov | ||
| "... инфаркта миокарда. Рассматриваются результаты крупного рандомизированного плацебо-контролируемого ..." | ||
| Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
| "... со стабильной стенокардией напряжения. Материал и методы. В рандомизированное двойное слепое плацебо ..." | ||
| Vol 3, No 5 (2007) | FEMALE SEX HORMONES AS MODULATORS OF GENDER DIFFERENCES IN RESPONSE TO PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, E. S. Krasilnikova, E. E. Kazantseva | ||
| "... . Приведены данные ретроспективных и плацебо-контролируемых исследований, проведенных в разных странах ..." | ||
| Vol 9, No 5 (2013) | THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION | Abstract similar documents |
| R. N. Adzhiev, M. S. Safarova, M. V. Ezhov | ||
| "... Review of large of trials that prove the positive impact of high-dose lipid-lowering therapy ..." | ||
| Vol 8, No 2 (2012) | IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? | Abstract similar documents |
| D. V. Nebieridze, T. V. Kamyshova | ||
| "... , endothelial dysfunction, lipid profile, and plasma fibrinolytic activity are considered. ..." | ||
| Vol 9, No 3 (2013) | EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA) | Abstract similar documents |
| , , , , , , , , , , , | ||
| "... Цель. Изучить влияние терапии ранолазином по сравнению с плацебо на еженедельную частоту приступов ..." | ||
| Vol 7, No 1 (2011) | DYSLIPIDEMIA FEATURES IN CHILDREN | Abstract similar documents |
| T. I. Turkinа, M. Yu. Shcherbakova | ||
| "... Contemporary scientific and practical data about various lipid metabolism disorders (dyslipidemia ..." | ||
| Vol 17, No 1 (2021) | Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council | Abstract similar documents |
| M. V. Ezhov, V. V. Kukharchuk, I. V. Sergienko, N. M. Akhmedzhanov, M. I. Voevoda, V. S. Gurevich, V. V. Kashtalap, V. O. Konstantinov, V. V. Skibitsky, I. I. Shaposhnik | ||
| "... hypercholesterolemia / mixed dyslipidemia, the modern evidence base for lipid-lowering therapy and the practical value ..." | ||
| Vol 7, No 2 (2011) | EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS ON LEFT VENTRICULAR FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH DILATED CARDIOMYOPATHY | Abstract similar documents |
| S. Nodari, M. Triggiani, U. Campia, A. Manerba, G. Milesi, B. M. Cesana, M. Gheorghiade, L. Dei Cas | ||
| "... терапии. Больные были рандомизированы в группы лечения плацебо или n-3 ПНЖК в дозе 2 г/сут. До начала ..." | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... с плацебо, однако выявлена гетерогенность между различными классами. Обнаружено статистически ..." | ||
| Vol 10, No 2 (2014) | RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL | Abstract similar documents |
| J. L. Mega, E. Braunwald, S. A. Murphy, A. N. Plotnikov, P. Burton, R. G. Kiss, A. Parkhomenko, M. Tendera, P. Widimsky, C. M. Gibson | ||
| "... лечения ривароксабаном в дозе 2,5 мг 2 р/д, ривароксабаном в дозе 5 мг 2 р/д, или плацебо. Результаты ..." | ||
| Vol 2, No 1 (2006) | DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT | Abstract similar documents |
| O. V. Andropova, V. N. Anokhin | ||
| "... computed tomography. Markers of inflammation and lipid profile were investigated. Results. Higher blood ..." | ||
| Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
| L. N. Malay | ||
| "... Statins, the most common drugs for reduction in lipid levels, are “strategic” medicinal products ..." | ||
| Vol 3, No 5 (2007) | BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME | Abstract similar documents |
| V. A. Nevzorova, N. V. Zakcharchuk, O. V. Nastradin, O. G. Pomogalova | ||
| "... and metformin. Blood pressure (BP), body mass index (BMI), carbohydrate metabolism, lipid profile ..." | ||
| Vol 2, No 4 (2006) | CLINICAL EFFICACY OF MONOTHERAPY WITH INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION OF THE I-II DEGREES | Abstract similar documents |
| E. Yu. Тourkassova, T. G. Volkova, E. M. Idrissova, E. M. Vorobyeva, R. S. Karpov | ||
| "... , Russia) and its influence on blood levels of carbohydrates, lipids and electrolytes in patients ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... Besides hypolipidemic effect statins demonstrate some not-lipid (pleotropic) ones. Special ..." | ||
| Vol 10, No 5 (2014) | RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME | Abstract similar documents |
| N. V. Perova, V. A. Metelskaya | ||
| "... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..." | ||
| Vol 2, No 2 (2006) | METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS | Abstract similar documents |
| N. V. Perova, I. N. Ozerova, V. A. Metelskaya | ||
| "... Lipid metabolism issues are reviewed. Ways of cholesterol transformation are represented ..." | ||
| Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
| S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
| "... lipid-lowering therapy compared with standard therapy is proven in patients with both stable and acute ..." | ||
| Vol 16, No 1 (2020) | Cross-Sectional Study to Estimate the Prevalence of Familial Hypercholesterolemia in Selected Regions of the Russian Federation: Relevance, Design of the Study and Initial Characteristics of the Participants | Abstract similar documents |
| A. N. Meshkov, A. I. Ershova, S. A. Shalnova, A. S. Alieva, S. S. Bazhan, O. L. Barbarash, D. Y. Bogdanov, I. A. Viktorova, Yu. I. Grinshtein, D. V. Duplyakov, O. N. Kalachikova, A. V. Kontsevaya, R. A. Libis, I. V. Medvedeva, V. A. Nevzorova, N. N. Prishchepa, O. P. Rotar, V. N. Serebryakova, I. A. Trubacheva, T. M. Chernykh, E. A. Shutemova, O. M. Drapkina, S. A. Boytsov | ||
| "... and duration of lipid-lowering therapy throughout life, presence and dates of secondary causes ..." | ||
| Vol 9, No 4 (2013) | EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE | Abstract PDF (Eng) similar documents |
| G. A. Batrak, S. E. Miasoedova, O. I. Kelesh | ||
| "... and target lipid levels achievement. Material and methods. The total of 161 type 2 diabetic patients ..." | ||
| Vol 16, No 1 (2020) | Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease | Abstract similar documents |
| A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko | ||
| "... , alirocumab, on lipid levels in patients who receive secondary prevention of cardiovascular diseases (CVD ..." | ||
| Vol 1, No 3 (2005) | PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE | Abstract similar documents |
| V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova | ||
| "... hypertension (AH); to evaluate dynamics of cerebral blood flow parameters and plasma lipid concentrations ..." | ||
| Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
| M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
| "... cholesterol (LDL-C) as the primary target in addressing lipid-lowering therapy. The target level of LDL-C ..." | ||
| Vol 12, No 6 (2016) | THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev | ||
| "... , через 2 нед дозу увеличивали до 20 мг 2 р/сут. Больным контрольной группы к лечению добавляли плацебо ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... Widespread use of antihypertensive and lipid-lowering agents in clinical practice determines ..." | ||
| Vol 7, No 1 (2011) | ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT? | Abstract similar documents |
| L. N. Malay | ||
| "... on the soft end (lipid profile) and hard end (number of heart attacks, strokes, heart failure, hospitalization ..." | ||
| Vol 16, No 1 (2020) | The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion) | Abstract similar documents |
| M. V. Ezhov, A. Catapano, C. Escobar, V. V. Kukharchuk, M. I. Voevoda, O. M. Drapkina, S. A. Shalnova, A. V. Starodubova, V. S. Gurevich, I. I. Shaposhnik, O. O. Bolshakova, O. S. Oynotkinova, A. S. Alieva | ||
| "... with the prospect of lifelong therapy with lipid-lowering drugs. These individuals do not have an indication ..." | ||
| Vol 1, No 1 (2005) | MENOPAUSE AND CARDIOVASCULAR RISK | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva | ||
| "... , lipid-lowering and antihypertensive treatment should be considered for cardiovascular risk reduction ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... components according to multifactor origin of cardiovascular disease (CVD). Correction of lipid metabolism ..." | ||
| Vol 5, No 3 (2009) | ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT | Abstract similar documents |
| V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko | ||
| "... and lipid profiles were assessed before therapy and in 1, 2, 6 and 12 month of the observation. Non-invasive ..." | ||
| Vol 5, No 3 (2009) | HEMODYNAMIC INSIGNIFICANT CAROTID ARTERIES STENOSIS AND RISK OF EMBOLIC STROKE IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| V. V. Semenova, A. N. Zakirova | ||
| "... in all patients as well as lipid spectrum, fibrinogen level and blood D-diameter concentration were ..." | ||
| Vol 5, No 5 (2009) | LONG-TERM THERAPY WITH INDAPAMIDE IN ELDERLY AND SENILE PATIENTS WITH HYPERTENSION: CARDIORENOPROTECTIVE EFFECTS AND INFLUENCE ON QUALITY OF LIFE | Abstract similar documents |
| M. E. Statsenko, T. G. Sherbakova, S. V. Belenkova, O. E. Sporova | ||
| "... lipid profile, glycemia and uricemia levels and potassium serum level was evaluated initially and after ..." | ||
| Vol 14, No 5 (2018) | Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria | Abstract similar documents |
| Yu. N. Belenkov, E. V. Privalova, V. Y. Kaplunova, V. Y. Zektser, N. N. Vinogradova, I. S. Ilgisonis, G. A. Shakaryants, M. V. Kozhevnikova, A. S. Lishuta | ||
| "... and lipid metabolism, arterial hypertension, and close pathogenic relationship between these factors ..." | ||
| Vol 4, No 3 (2008) | COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME | Abstract similar documents |
| E. I. Mananko, E. A. Bushkova, E. M. Idrisova, A. I. Vengerovsky | ||
| "... on blood pressure (BP), myocardial mass and diastolic function of left ventricular, lipid and carbohydrate ..." | ||
| 1 - 100 of 230 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
